Clinical Trials Logo

Fear of Cancer clinical trials

View clinical trials related to Fear of Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT05604365 Completed - Glioma Clinical Trials

FearLess in Cognitively Intact Patients With Glioma

FearLess
Start date: November 7, 2022
Phase: N/A
Study type: Interventional

This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.

NCT ID: NCT03763825 Not yet recruiting - Breast Cancer Clinical Trials

Mini-AFTERc Intervention for Fear of Cancer Recurrence

Mini-AFTERc
Start date: June 13, 2019
Phase: N/A
Study type: Interventional

People treated for breast cancer often live with an ongoing fear that the cancer will recur. This fear may develop and impact on their mental health and quality of life. The Mini-AFTERc study is a pilot trial of a brief cognitive behavioural communication intervention, designed to reduce fear of cancer recurrence (FCR) in breast cancer patients. This pilot trial aims to determine the acceptability and practicality of introducing the Mini-AFTERc intervention into everyday practice, and inform the development of a full randomised controlled trial.

NCT ID: NCT03384992 Completed - Breast Cancer Clinical Trials

Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors

FoRtitude
Start date: March 2014
Phase: N/A
Study type: Interventional

The FoRtitude trial aims to evaluate an eHealth intervention designed to teach breast cancer survivors strategies to manage anxiety about cancer recurrence. The eHealth intervention includes educational content and interactive tools, designed to teach coping strategies and/or inert content, depending on the study participant's randomization assignment. The FoRtitude study will examine whether three coping strategies (relaxation training, cognitive restructuring, worry practice) are more effective than general health-related content in reducing fear of cancer recurrence.

NCT ID: NCT03336827 Completed - Breast Cancer Clinical Trials

Improving Emotion Regulation at the End of Breast Cancer Treatment

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The end of treatment marks the beginning of a challenging period for breast cancer patients. While this period often provokes a sense of relief, it can also be a source of apprehension and vulnerability regarding the future. Patients may be brought to feel contradictory thoughts and emotions impacting their quality of life such as anxiety linked to uncertainty and fear of cancer recurrence. In order to accompany breast cancer patients during this transition period and to address these emotional difficulties, the Institut Jules Bordet has launched an 8-session psychological multi-component group intervention. Its objective is to bring patients tools and competencies (e.g., hypnosis, treatment of intrusive thoughts, learning to cope with uncertainty, attention reorientation toward positive thoughts) to promote emotion management and well-being.